Metraipolis › archive › dc_e73f81296076
Phase II trial protocol of focal prostate ablation combined with androgen deprivation therapy for prostate cancer treatment — Europe PMC PMID:41401176
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41401176
- DOI
- 10.1371/journal.pone.0337828
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:00:16.224Z
- SHA-256 of the archived text
1a0301488a4fe86870fd7d43597c128076c2a78d2d4115df2e0fb3a1d6dedafe- Stable URL of this page
https://metraipolis.com/documento/dc_e73f81296076
How to cite
Phase II trial protocol of focal prostate ablation combined with androgen deprivation therapy for prostate cancer treatment — Europe PMC PMID:41401176 — Europe PMC (en), https://europepmc.org/article/MED/41401176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e73f81296076 (Metraipolis archive dc_e73f81296076, sha256 1a0301488a4fe86870fd7d43597c128076c2a78d2d4115df2e0fb3a1d6dedafe)
BibTeX
@misc{dce73f81296076,
title = {Phase II trial protocol of focal prostate ablation combined with androgen deprivation therapy for prostate cancer treatment — Europe PMC PMID:41401176},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41401176},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e73f81296076; sha256 1a0301488a4fe86870fd7d43597c128076c2a78d2d4115df2e0fb3a1d6dedafe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41401176. Agents can read the archived copy with the MCP tool read_document.